No genetic clock for neuron longevity
February 27, 2013
by Marcia Malory
in Neuroscience
Image of pyramidal neurons in mouse cerebral cortex expressing green fluorescent protein. The red staining indicates GABAergic interneurons. (Source PLoS Biology). Image via Wikimedia Commons.
(Medical Xpress)—People are living longer than ever before, thanks to medical and technological advances. Unfortunately, aging can be associated with a decrease in brain function. This is because, unlike other cells in the body, neurons do not replicate. Neuroscientists in Italy have extended the lives of mouse neurons by injecting them into the brains of longer-lived rats, according to a study published in Proceedings of the National Academy of Sciences. This indicates that neuronal lifespan is not predetermined, but depends on conditions in the microenvironment.
After injecting green fluorescent protein into neuron precursor cells in the embryos of mice with an average lifespan of 18 months, Lorenzo Magrassi of the University of Pavia and his team transplanted the cells into the fetuses of Wistar rats, which live twice as long. Once the cells had differentiated, the researchers focused on a type of neuron called a Purkinje Cell (PC). Mice lose almost half of their PCs long before they reach old age. Wistar rats, on the other hand, keep almost all of their PCs until they die.
The researchers euthanized the rats after three years. When they examined the rats' brains, they found that the transplanted PCs had survived until the animals' deaths. The neurons showed the same signs of aging as neighboring rat neurons.
Although Magrassi and his colleagues were able to increase the lifespans of the transplanted neurons significantly, the transplantation did not alter all of the neurons' characteristics. The PCs retained the small size normally found in mice.
Magrassi says that the research proves that the longevity of neurons is not predetermined. Our brain cells do not have a genetic clock that tells them when to die. Instead, the microenvironment of the brain plays an important role in deciding how long neurons will live. He claims that by injecting neurons into species that live even longer, scientists could increase neuronal lifespan still more.
The research indicates that an aging body need not imply an aging brain. According to Magrassi, the findings suggest that neuronal implants could help people suffering from degenerative diseases such as Alzheimer's disease and Parkinson's disease.
Now, the team is trying to find out why PCs survive so much longer in rats than in mice by comparing the proteomes of the transplanted neurons with those of the host neurons. In an email to The Scientist, Gilbert Bernier, a molecular biologist at the University of Montreal who was not involved in the study, suggested that mice could be losing their PCs because of other types of neurons or because of inflammation caused by immune cells.
More information: Lifespan of neurons is uncoupled from organismal lifespan, PNAS, 2013. doi: 10.1073/pnas.1217505110
Abstract
Neurons in mammals do not undergo replicative aging, and, in absence of pathologic conditions, their lifespan is limited only by the maximum lifespan of the organism. Whether neuronal lifespan is determined by the strain-specific lifetime or can be extended beyond this limit is unknown. Here, we transplanted embryonic mouse cerebellar precursors into the developing brain of the longer-living Wistar rats. The donor cells integrated into the rat cerebellum developing into mature neurons while retaining mouse-specific morphometric traits. In their new environment, the grafted mouse neurons did not die at or before the maximum lifespan of their strain of origin but survived as long as 36 mo, doubling the average lifespan of the donor mice. Thus, the lifespan of neurons is not limited by the maximum lifespan of the donor organism, but continues when transplanted in a longer-living host.
Journal reference:
Proceedings of the National Academy of Sciences
(c) 2013 Medical Xpress
-
Neurons made from stem cells drive brain activity after transplantation in laboratory model
Nov 15, 2012 |
not rated yet |
0
-
New research links proteins, stem cells and potential Alzheimer's treatment
Aug 06, 2007 |
not rated yet |
0
-
Brain structure adapts to environmental change
Jun 13, 2011 |
not rated yet |
0
-
Replacing faulty neurons
Nov 05, 2010 |
not rated yet |
0
-
Stem-cell therapies for brain more complicated than thought
Nov 27, 2007 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
Why is zone 1 in liver more prone to ischemic injury?
7 hours ago
-
How can there be villous adenoma in colon, if there are no villi there
May 22, 2013
-
How can there be a term called "intestinal metaplasia" of stomach
May 21, 2013
-
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013
-
If you became brain-dead, would you want them to pull the plug?
May 17, 2013
-
MRI bill question
May 15, 2013
- More from Physics Forums - Medical Sciences
More news stories
Breakthrough on Huntington's disease
Researchers at Lund University have succeeded in preventing very early symptoms of Huntington's disease, depression and anxiety, by deactivating the mutated huntingtin protein in the brains of mice.
Neuroscience
5 minutes ago |
not rated yet |
0
Researchers identify networks of neurons in the brain that are disrupted in psychiatric disease
Studying the networks of connections in the brains of people affected by schizophrenia, bipolar disease or depression has allowed Dr. Peter Williamson, from Western University, to gain a better understanding of the biological ...
Neuroscience
1 hour ago |
not rated yet |
0
Pay attention: How we focus and concentrate
Scientists at Newcastle University have shed new light on how the brain tunes in to relevant information.
Neuroscience
1 hour ago |
5 / 5 (1) |
0
|
New imaging techniques used to help patients suffering from epilepsy
New techniques in imaging of brain activity developed by Jean Gotman, from McGill University's Montreal Neurological Institute, and his colleagues lead to improved treatment of patients suffering from epilepsy. The combination ...
Neuroscience
1 hour ago |
not rated yet |
0
Common brain processes of anesthetic-induced unconsciousness identified
A study from the June issue of Anesthesiology found feedback from the front region of the brain is a crucial building block for consciousness and that its disruption is associated with unconsciousness when the anesthetics ketami ...
Neuroscience
2 hours ago |
5 / 5 (1) |
0
Researchers suggest boosting body's natural flu killers
A known difficulty in fighting influenza (flu) is the ability of the flu viruses to mutate and thus evade various medications that were previously found to be effective. Researchers at the Hebrew University of Jerusalem have ...
Anxious men fare worse during job interviews, study finds
Nervous about that upcoming job interview? You might want to take steps to reduce your jitters, especially if you are a man.
Frequent heartburn may predict cancers of the throat and vocal cord
Frequent heartburn was positively associated with cancers of the throat and vocal cord among nonsmokers and nondrinkers, and the use of antacids, but not prescription medications, had a protective effect, according to data ...
Second-generation TAVI device—Lotus Valve—shows good performance in REPRISE II
22 May 2013, Paris, France: The Lotus Valve, a second-generation transcatheter aortic valve implantation (TAVI) device, was successfully implanted in all of the first 60 patients in results from REPRISE II reported at EuroPCR ...
Major human drug trial underway for Alzheimer's
A potentially ground-breaking human drug trial is currently underway, which aims to discover whether blood pressure medication can slow or halt the progression of Alzheimer's Disease (AD). This is the latest ...
New discovery in fight against deadly meningococcal disease
Professor Michael Jennings, Deputy Director of the Institute for Glycomics at Griffith University, was part of an international team that discovered the previously unknown pathway of how the bacterium colonizes people.